New York, NY
The drug and device industries face a landscape that has been complicated by a reinvigorated FDA and by federal and state enforcement actions. Matters relating to manufacturing issues and product recalls, as well as government probes into both pre-market and post-marketing practices, are emerging frequently in civil litigation. In addition, social media has created a new environment where product information can go "viral" and influence both patients and jurors. In addition, a difficult economy has prompted in-house counsel to seek more cost effective ways to handle product liability litigation. Areas of focus will include:
For more information or to register, please visit www.drugandmed.com
You have no pages selected. Please select pages to email then resubmit.